Clinical TrialsSearch results
Number of results: 232
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
- Thymoma (excluding thymic carcinoma)
- Japanese Association for Research on the Thymus
- 2006-04-01
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01
Completed
- Investigator-initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc.(Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases-Randomized, Controlled, Crossover Study for Gait Improvement as a Short-Term Effect (Study NCY-3001)
- The target disease condition of this study is ambulation disorder due to intractable rare neuromuscular diseases. Examples of diseases and conditions to be included are: spinal muscular atrophy, spinal and bulbar muscular atrophy, amyotrophic lateral sclerosis with slowly progressive lower-limb symptoms, Charcot-Marie-Tooth disease, distal myopathy, sporadic inclusion body myositis, congenital myopathy, muscular dystrophy, and conditions considered equivalent to these diseases though not definitively diagnosed.
- Takashi Nakajima
- 2013-12-26
Completed
- Investigator-initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc.(Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases-Randomized, Controlled, Crossover Study for Gait Improvement as a Short-Term Effect (Study NCY-3001)
- The target disease condition of this study is ambulation disorder due to intractable rare neuromuscular diseases. Examples of diseases and conditions to be included are: spinal muscular atrophy, spinal and bulbar muscular atrophy, amyotrophic lateral sclerosis with slowly progressive lower-limb symptoms, Charcot-Marie-Tooth disease, distal myopathy, sporadic inclusion body myositis, congenital myopathy, muscular dystrophy, and conditions considered equivalent to these diseases though not definitively diagnosed.
- Takashi Nakajima
- 2013-12-26
Completed
- Investigator-initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc.(Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases-Randomized, Controlled, Crossover Study for Gait Improvement as a Short-Term Effect (Study NCY-3001)
- The target disease condition of this study is ambulation disorder due to intractable rare neuromuscular diseases. Examples of diseases and conditions to be included are: spinal muscular atrophy, spinal and bulbar muscular atrophy, amyotrophic lateral sclerosis with slowly progressive lower-limb symptoms, Charcot-Marie-Tooth disease, distal myopathy, sporadic inclusion body myositis, congenital myopathy, muscular dystrophy, and conditions considered equivalent to these diseases though not definitively diagnosed.
- Takashi Nakajima
- 2013-12-26
Completed
- Investigator-initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc.(Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases-Randomized, Controlled, Crossover Study for Gait Improvement as a Short-Term Effect (Study NCY-3001)
- The target disease condition of this study is ambulation disorder due to intractable rare neuromuscular diseases. Examples of diseases and conditions to be included are: spinal muscular atrophy, spinal and bulbar muscular atrophy, amyotrophic lateral sclerosis with slowly progressive lower-limb symptoms, Charcot-Marie-Tooth disease, distal myopathy, sporadic inclusion body myositis, congenital myopathy, muscular dystrophy, and conditions considered equivalent to these diseases though not definitively diagnosed.
- Takashi Nakajima
- 2013-12-26
Completed
- Investigator-initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc.(Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases-Randomized, Controlled, Crossover Study for Gait Improvement as a Short-Term Effect (Study NCY-3001)
- The target disease condition of this study is ambulation disorder due to intractable rare neuromuscular diseases. Examples of diseases and conditions to be included are: spinal muscular atrophy, spinal and bulbar muscular atrophy, amyotrophic lateral sclerosis with slowly progressive lower-limb symptoms, Charcot-Marie-Tooth disease, distal myopathy, sporadic inclusion body myositis, congenital myopathy, muscular dystrophy, and conditions considered equivalent to these diseases though not definitively diagnosed.
- Takashi Nakajima
- 2013-12-26
Completed
- Investigator-Initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc.,
(Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases
-A Multicenter Randomized Controlled Parallel-Group Study to Evaluate the Short-Term Gait Improvement Effect on Ambulation Disability Caused by Spastic Paraplegia such as HTLV-1-Associated Myelopathy (HAM) etc.-
(Study NCY-2001)
- The target disease condition of this study is ambulation disability caused by spastic paraplegia resulting from HTLV-1-Associated Myelopathy (HAM) according to HAM/TSP diagnostic guidelines (from the 1988 Kagoshima WHO Scientific Council), as well as ambulation disability occurring from chronic monophasic spastic paraplegia similar to HAM resulting from other causes (hereinafter, "Ambulation disability caused by HAM, etc."). Examples of diseases and conditions to be included in chronic monophasic spastic paraplegia are: hereditary spastic paraplegia, traumatic spinal cord injury, spinal vascular disorders, myelitis, cured spinal cord tumors, ossification of posterior longitudinal ligament that is orthopedically stable due to surgeries and allows for the burden of walking, ossification of yellow ligament, and spondylosis as non-traumatic spinal cord injuries, and conditions clinically equivalent to these diseases though its cause cannot be identified as one of the aforementioned.
- Takashi Nakajima
- 2014-12-17
Completed
- Investigator-Initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc.,
(Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases
-A Multicenter Randomized Controlled Parallel-Group Study to Evaluate the Short-Term Gait Improvement Effect on Ambulation Disability Caused by Spastic Paraplegia such as HTLV-1-Associated Myelopathy (HAM) etc.-
(Study NCY-2001)
- The target disease condition of this study is ambulation disability caused by spastic paraplegia resulting from HTLV-1-Associated Myelopathy (HAM) according to HAM/TSP diagnostic guidelines (from the 1988 Kagoshima WHO Scientific Council), as well as ambulation disability occurring from chronic monophasic spastic paraplegia similar to HAM resulting from other causes (hereinafter, "Ambulation disability caused by HAM, etc."). Examples of diseases and conditions to be included in chronic monophasic spastic paraplegia are: hereditary spastic paraplegia, traumatic spinal cord injury, spinal vascular disorders, myelitis, cured spinal cord tumors, ossification of posterior longitudinal ligament that is orthopedically stable due to surgeries and allows for the burden of walking, ossification of yellow ligament, and spondylosis as non-traumatic spinal cord injuries, and conditions clinically equivalent to these diseases though its cause cannot be identified as one of the aforementioned.
- Takashi Nakajima
- 2014-12-17
Completed
- Investigator-Initiated Clinical Study of Wearable Assistive Robot for Lower Limbs Controlled Voluntarily by Bioelectric Signals etc.,
(Hybrid Assistive Limb [HAL]-HN01) as a New Medical Device to Delay Progression of Intractable Rare Neuromuscular Diseases
-A Multicenter Randomized Controlled Parallel-Group Study to Evaluate the Short-Term Gait Improvement Effect on Ambulation Disability Caused by Spastic Paraplegia such as HTLV-1-Associated Myelopathy (HAM) etc.-
(Study NCY-2001)
- The target disease condition of this study is ambulation disability caused by spastic paraplegia resulting from HTLV-1-Associated Myelopathy (HAM) according to HAM/TSP diagnostic guidelines (from the 1988 Kagoshima WHO Scientific Council), as well as ambulation disability occurring from chronic monophasic spastic paraplegia similar to HAM resulting from other causes (hereinafter, "Ambulation disability caused by HAM, etc."). Examples of diseases and conditions to be included in chronic monophasic spastic paraplegia are: hereditary spastic paraplegia, traumatic spinal cord injury, spinal vascular disorders, myelitis, cured spinal cord tumors, ossification of posterior longitudinal ligament that is orthopedically stable due to surgeries and allows for the burden of walking, ossification of yellow ligament, and spondylosis as non-traumatic spinal cord injuries, and conditions clinically equivalent to these diseases though its cause cannot be identified as one of the aforementioned.
- Takashi Nakajima
- 2014-12-17